{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:32:27Z","timestamp":1777923147844,"version":"3.51.4"},"reference-count":64,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>The opioid misuse epidemic is a serious public health crisis. Opioid-involved deaths continue to rise and the potency of illicitly manufactured synthetic opioids has increased, creating challenges for the healthcare system to provide multifaceted specialized care. Elements of the regulation around buprenorphine, 1 of 3 drugs approved to treat opioid use disorder (OUD), constrain treatment options for patients and providers alike. Updates to this regulatory framework, particularly around dosing and access to care, would enable providers to better treat the changing landscape of opioid misuse. Specific actions to this end are to: (1) Increase buprenorphine dosing flexibility based on FDA labeling which drives payor policies; (2) Restrict local government and institutional impositions of arbitrary access and dosing limits for buprenorphine; and (3) Liberalize buprenorphine initiation and maintenance via telemedicine for OUD.<\/jats:p>","DOI":"10.1177\/08897077231165619","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T05:59:32Z","timestamp":1684994372000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals"],"prefix":"10.1177","volume":"44","author":[{"given":"David Tyler","family":"Coyle","sequence":"first","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Stewart","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"Bortz","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Manalo","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Ritvo","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Krsak","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"bibr1-08897077231165619","unstructured":"Centers for Disease Control and Prevention. Drug overdose deaths in the U.S. top 100,000 annually. Accessed April 28, 2022. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm"},{"key":"bibr2-08897077231165619","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm675152e1"},{"key":"bibr3-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0625-0"},{"key":"bibr4-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"bibr5-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103051"},{"key":"bibr6-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0094-5"},{"key":"bibr7-08897077231165619","volume":"17","author":"Baser O","year":"2011","journal-title":"Am J Manag Care"},{"key":"bibr8-08897077231165619","unstructured":"American Society of Addiction Medicine. National practice guidelines for the use of medications in the treatment of addiction involving opioid use. 2015. Accessed November 8, 2022. https:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guideline-pocketguide.pdf"},{"key":"bibr9-08897077231165619","unstructured":"Code of Federal Regulations, title 42 (version\u2019s last amendment 11\/7\/22). 2001. Accessed November 13, 2022. https:\/\/www.ecfr.gov\/current\/title-42\/chapter-I\/subchapter-A\/part-8"},{"key":"bibr10-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1694536"},{"key":"bibr11-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109107"},{"key":"bibr12-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1975344"},{"key":"bibr13-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1097\/CXA.0000000000000072"},{"key":"bibr14-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13135"},{"issue":"19","key":"bibr15-08897077231165619","first-page":"124","volume":"24","author":"Saal D","year":"2020","journal-title":"Perm J"},{"key":"bibr16-08897077231165619","unstructured":"Drugs@FDA. Suboxone label. 2022. Accessed November 8, 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/022410s046s047lbl.pdf"},{"key":"bibr17-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2020.07.004"},{"key":"bibr18-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.17128"},{"key":"bibr19-08897077231165619","unstructured":"Bridge CA. Buprenorphine emergency department quick start. 2022. Accessed November 15, 2022. https:\/\/cabridge.org\/resource\/buprenorphine-bup-hospital-quick-start\/"},{"key":"bibr20-08897077231165619","unstructured":"American College of Emergency Physicians. Buprenorphine use in the emergency department tool. 2018. Accessed on November 15, 2022. https:\/\/www.acep.org\/patient-care\/bupe\/"},{"key":"bibr21-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.1553"},{"key":"bibr22-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00110-X"},{"key":"bibr23-08897077231165619","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"bibr24-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1111\/add.12333"},{"key":"bibr25-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108317"},{"key":"bibr26-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.642758"},{"key":"bibr27-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00223-z"},{"key":"bibr28-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-3055-z"},{"key":"bibr29-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00637-z"},{"key":"bibr30-08897077231165619","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060816"},{"key":"bibr31-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1177\/0009922819829038"},{"key":"bibr32-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-020-00795-3"},{"key":"bibr33-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/57.2.192"},{"key":"bibr34-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.06.025"},{"key":"bibr35-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300251"},{"key":"bibr36-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.07.035"},{"key":"bibr37-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"bibr38-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000427"},{"key":"bibr39-08897077231165619","unstructured":"American Society of Addiction Medicine. National practice guideline 2020 focused update. 2020. Accessed November 8, 2022. https:\/\/www.asam.org\/quality-care\/clinical-guidelines\/national-practice-guideline"},{"key":"bibr40-08897077231165619","volume":"3","author":"Mattick RP","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr41-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.07.005"},{"key":"bibr42-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"bibr43-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1186\/s40352-022-00178-6"},{"key":"bibr44-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1944958"},{"key":"bibr45-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2171107"},{"key":"bibr46-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1967836"},{"key":"bibr47-08897077231165619","unstructured":"Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009. Special report. Office of Justice Programs, Bureau of Justice Statistics, US Department of Justice. 2017. Accessed November 16, 2022. https:\/\/bjs.ojp.gov\/content\/pub\/pdf\/dudaspji0709.pdf"},{"key":"bibr48-08897077231165619","unstructured":"HIPAA Guidelines on Telemedicine. 2022. Accessed November 16, 2022. https:\/\/www.hipaajournal.com\/hipaa-guidelines-on-telemedicine\/"},{"key":"bibr49-08897077231165619","unstructured":"HIPAA & Telehealth. A stepwise guide to compliance. 2022. Accessed November 16, 2022. https:\/\/www.ssa.gov\/ndf\/documents\/HIPAA%20Project-1027.pdf"},{"key":"bibr50-08897077231165619","unstructured":"Telehealth Licensing and Interstate Compacts. Health & Human Services (last updated 9\/28\/22). 2022. Accessed November 16, 2022. https:\/\/telehealth.hhs.gov\/providers\/policy-changes-during-the-covid-19-public-health-emergency\/telehealth-licensing-requirements-and-interstate-compacts\/"},{"key":"bibr51-08897077231165619","unstructured":"Interstate Medical Licensure Compact. A Faster Pathway to Physician Licensure. 2021. Accessed on November 16, 2022. https:\/\/www.imlcc.org\/a-faster-pathway-to-physician-licensure\/"},{"key":"bibr52-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa001"},{"key":"bibr53-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108492"},{"key":"bibr54-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.21111141"},{"key":"bibr55-08897077231165619","unstructured":"Consolidated Appropriations Act of 2023. 2023. Accessed March 1, 2023. https:\/\/www.appropriations.senate.gov\/imo\/media\/doc\/JRQ121922.PDF"},{"key":"bibr56-08897077231165619","unstructured":"Rettig R, Yarmolinsky A, eds. Institute of medicine committee on federal regulation of methadone treatment. National Academies Press; 1995. Accessed February 21, 2023 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK232114\/"},{"key":"bibr57-08897077231165619","unstructured":"Tennessee Nonresidential Buprenorphine Treatment Guidelines, 2021 Update. 2021. Accessed May 2, 2022. https:\/\/www.tn.gov\/content\/dam\/tn\/mentalhealth\/documents\/2018_Buprenorphine_Treatment_Guidelines.PDF"},{"key":"bibr58-08897077231165619","unstructured":"Washington State Health Care Authority. Medication Treatment Guidelines for Substance Use Disorders (SUDs) \u2013 Transmucosal Buprenorphine. Accessed April 28, 2022. https:\/\/www.hca.wa.gov\/assets\/billers-and-providers\/MAT_buprenorphine_products.pdf"},{"key":"bibr59-08897077231165619","author":"Cundiff D, Grande L","year":"2022","journal-title":"American Society of Addiction Medicine Annual Meeting"},{"key":"bibr60-08897077231165619","unstructured":"McBournie A, Duncan A, Connolly E, Rising J. Methadone barriers persist, despite decades of evidence. Health Affairs Forefront. September 23, 2019; Accessed November 13, 2022. https:\/\/www.healthaffairs.org\/do\/10.1377\/forefront.20190920.981503"},{"key":"bibr61-08897077231165619","unstructured":"Opioid Treatment Access Act of 2022, press release. 2022. Accessed November 13, 2022. https:\/\/www.markey.senate.gov\/news\/press-releases\/senators-markey-and-paul-introduce-bipartisan-legislation-to-modernize-improve-methadone-treatment-amid-skyrocketing-opioid-overdoses-and-deaths"},{"key":"bibr62-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1776"},{"key":"bibr63-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.05.002"},{"key":"bibr64-08897077231165619","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1572052"}],"updated-by":[{"DOI":"10.1177\/08897077231185670","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000}}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231165619","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08897077231165619","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231165619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:40:11Z","timestamp":1777668011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08897077231165619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":64,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1177\/08897077231165619"],"URL":"https:\/\/doi.org\/10.1177\/08897077231165619","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}